Risk factors of work disability in patients with inflammatory bowel disease - A Dutch nationwide web-based survey. Work disability in inflammatory bowel disease.

Journal of Crohn's and Colitis

Volumn 8, Issue 7, 2014, Pages 590-597

  van der Valk, Mirthe E ^a   Mangen, Marie Josée J ^a   Leenders, Max ^a   Dijkstra, Gerard ^b   van Bodegraven, Ad A ^c   Fidder, Herma H ^a   de Jong, Dirk J ^d   Pierik, Marieke ^e   van der Woude, C Janneke ^f   Romberg Camps, Mariëlle J L ^g   Clemens, Cees H M ^h   Jansen, Jeroen M ^h   Mahmmod, Nofel ⁱ   van de Meeberg, Paul C ^j   van der Meulen de Jong, Andrea E ^k   Ponsioen, Cyriel Y ^l   Bolwerk, Clemens J M ^m   Vermeijden, J Reinoud ⁿ   Siersema, Peter D ^a   van Oijen, Martijn G H ^a,o   Oldenburg, Bas ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Sittard Geleen Heerlen   (Netherlands)

^h Department of Gastroenterology and Hepatology Orbis Medical Centre ^*  (Netherlands)

ⁱ ST ANTONIUS HOSPITAL   (Netherlands)

^j SLINGELAND HOSPITAL   (Netherlands)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m REINIER DE GRAAF HOSPITAL   (Netherlands)

ⁿ MEANDER MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Crohn's disease; Risk factors; Ulcerative colitis; Work disability

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; BACKACHE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GENERAL HOSPITAL; HUMAN; INFLAMMATORY BOWEL DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL; WORK DISABILITY; AGE; BACK PAIN; CHRONIC PAIN; COLITIS, ULCERATIVE; DISABLED PERSON; MIDDLE AGED; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; WORK CAPACITY; YOUNG ADULT;

ADULT; AGE FACTORS; BACK PAIN; CHRONIC PAIN; COLITIS, ULCERATIVE; CROHN DISEASE; DEPRESSION; DISABLED PERSONS; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WORK CAPACITY EVALUATION; YOUNG ADULT;

EID: 84901498739     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.11.019     Document Type: Article

References (28)

1. Burisch J., Jess T., Martinato M., Lakatos P.L. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013, 7:322-337.
2. Ananthakrishnan A.N., Weber L.R., Knox J.F., Skaros S., Emmons J., Lundeen S., et al. Permanent work disability in Crohn's disease. Am J Gastroenterol 2008, 103:154-161.
3. Bernklev T., Jahnsen J., Henriksen M., Lygren I., Aadland E., Sauar J., et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:402-412.
4. Boonen A., Dagnelie P.C., Feleus A., Hesselink M.A., Muris J.W., Stockbrugger R.W., et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 2002, 8:382-389.
5. Feagan B.G., Bala M., Yan S., Olson A., Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol 2005, 39:390-395.
6. Hoivik M.L., Moum B., Solberg I.C., Henriksen M., Cvancarova M., Bernklev T. Work disability in inflammatory bowel disease patients 10years after disease onset: results from the IBSEN Study. Gut 2013, 62:368-375.
7. Juan J., Estiarte R., Colome E., Artes M., Jimenez F.J., Alonso J. Burden of illness of Crohn's disease in Spain. Dig Liver Dis 2003, 35:853-861.
8. Reinisch W., Sandborn W.J., Bala M., Yan S., Feagan B.G., Rutgeerts P., et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis 2007, 13:1135-1140.
9. Stark R., Konig H.H., Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006, 24:797-814.
10. Sulz M.C., Siebert U., Arvandi M., Gothe R.M., Wurm J., von K.R., et al. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol 2013, 25:790-797.
11. Gibson T.B., Ng E., Ozminkowski R.J., Wang S., Burton W.N., Goetzel R.Z., et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med 2008, 50:1261-1272.
12. Mesterton J., Jonsson L., Almer S.H., Befrits R., Friis-Liby I., Lindgren S. Resource use and societal costs for Crohn's disease in Sweden. Inflamm Bowel Dis 2009, 15:1882-1890.
13. van d.V., Mangen M.J., Leenders M., Dijkstra G., van Bodegraven A.A., Fidder H.H., et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study. Gut 2014, 63:72-79.
14. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010, 362:1383-1395.
15. Feagan B.G., Panaccione R., Sandborn W.J., D'Haens G.R., Schreiber S., Rutgeerts P.J., et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008, 135:1493-1499.
16. Lichtenstein G.R., Yan S., Bala M., Hanauer S. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2004, 99:91-96.
17. Feagan B.G., Reilly M.C., Gerlier L., Brabant Y., Brown M., Schreiber S. Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study. Aliment Pharmacol Ther 2010, 31:1276-1285.
18. Lichtiger S., Binion D.G., Wolf D.C., Present D.H., Bensimon A.G., Wu E., et al. The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment Pharmacol Ther 2010, 32:1228-1239.
19. http://www.government.nl.
20. Statistics Netherland Available at. http://www.cbs.nl.
21. World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Available at, [2001]. http://www.who.int/classifications/icf/wha-en.pdf.
22. Schwartz D.A., Pemberton J.H., Sandborn W.J. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med 2001, 135:906-918. [%20].
23. Schwartz D.A., Loftus E.V., Tremaine W.J., Panaccione R., Harmsen W.S., Zinsmeister A.R., et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002, 122:875-880.
24. D'Haens G.R. Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol 2010, 7:86-92.
25. Oldenburg B., Hommes D. Biological therapies in inflammatory bowel disease: top-down or bottom-up?. Curr Opin Gastroenterol 2007, 23:395-399.
26. Orchard T.R., Wordsworth B.P., Jewell D.P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998, 42:387-391.
27. Brakenhoff L.K., van der Heijde D.M., Hommes D.W. IBD and arthropathies: a practical approach to its diagnosis and management. Gut 2011, 60:1426-1435.
28. Bernstein C.N., Blanchard J.F., Rawsthorne P., Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999, 149:916-924.